Results 241 to 250 of about 4,150,951 (316)

A Morphological Study of Drug Brand Names [PDF]

, 2013
Williamson, Celina M
core   +1 more source

Epigenome Modifying Tools In Asthma [PDF]

, 2015
Adcock,, Brook, PO, Durham, AL, Perry, M
core   +1 more source

Oral Challenge with Trimethoprim‐Sulfamethoxazole in Patients with “Sulfa” Antibiotic Allergy Referred to an Outpatient Drug Allergy Clinic: 634

Journal of Allergy and Clinical Immunology: In Practice, 2019
M. Krantz, C. Stone, A. Abreo, E. Phillips   +3 more
semanticscholar   +1 more source

Global differences and risk factors influencing drug hypersensitivity quality of life: A multicenter, multiethnic study of drug allergy across 3 continents. [PDF]

J Allergy Clin Immunol Glob
Copaescu AM, Mak HWF, Vogrin S, Holmes NE, Trubiano JA, Li PH.   +5 more
europepmc   +1 more source

Cefotaxime desensitization [PDF]

, 1993
Bogner, Johannes R., Hehlmann, R., Hofmeister, F., Papakonstantino, G.   +3 more
core   +1 more source

Is there a connection between drug allergy and exotoxins?

, 2013
Lyudmila Akhmaltdinova
openalex   +2 more sources

Standardization of Terminology, Definitions, and Outcome Criteria for Bleeding in Hereditary Hemorrhagic Telangiectasia: International Consensus Report

American Journal of Hematology, EarlyView.
ABSTRACT Hereditary hemorrhagic telangiectasia (HHT, Osler‐Weber‐Rendu disease) is the second most common inherited bleeding disorder worldwide, affecting approximately 1 in 5000 people. Development of disease‐modifying and efficacious hemostatic agents to treat HHT has finally begun after decades without such medical therapies.
Hanny Al‐Samkari, Raj S. Kasthuri, Hans‐Jurgen Mager, Jenny Y. Zhou, Marcelo M. Serra, Bethany T. Samuelson‐Bannow, Layla N. Van Doren, Jay F. Piccirillo, Marianne S. Clancy, Keith R. McCrae, Sonia M. Thomas, Antoni Riera‐Mestre, Allyson M. Pishko, Sarah Sewaralthahab, James R. Gossage, Vivek N. Iyer, Cedric Hermans, Adrienne Hammill, Ingrid Winship, Meir Mei‐Zahav, Annette von Drygalski, Scott Olitsky, Marie E. Faughnan   +22 more
wiley   +1 more source

When leuprolide acetate is essential to care: A review of the literature and framework for assessing drug allergy. [PDF]

J Allergy Clin Immunol Glob
Belmont AP, Rosano J, Criscione J, Stone CA, Leeds S.   +4 more
europepmc   +1 more source

Determinants of 15‐Year Progression‐Free Survival in Multiple Myeloma; Real‐World Data From a Single Institution

American Journal of Hematology, EarlyView.
9% of patients with multiple myeloma achieve 15‐year progression‐free survival; Kaplan‐Meier curves for PFS (A) and OS (B). ABSTRACT The therapeutic advances during the last two decades have rendered multiple myeloma a chronic disease and, thus, it is important to identify patient subgroups which may have extremely favorable outcomes and optimize their
Meletios A. Dimopoulos, Ioannis Ntanasis‐Stathopoulos, Despina Fotiou, Foteini Theodorakakou, Eirini Solia, Vasiliki Spiliopoulou, Panagiotis Malandrakis, Erasmia Psimenou, Stavroula Giannouli, Nikolaos Kanellias, Vassilis Koutoulidis, Maria Roussou, Angeliki Andrikopoulou, Magdalini Migkou, Evangelos Eleutherakis‐Papaiakovou, Maria Gavriatopoulou, Evangelos Terpos, Efstathios Kastritis   +17 more
wiley   +1 more source

Dendrimeric Antigens for Drug Allergy Diagnosis: A New Approach for Basophil Activation Tests [PDF]

, 2018
Noemí Molina, Ángela Martín‐Serrano Ortiz, Tahía D. Fernández, Amene Tesfaye, Francisco Nájera, Marı́a José Torres, Cristobalina Mayorga, Yolanda Vida, María I. Montañez, Ezequiel Pérez‐Inestrosa   +9 more
openalex   +1 more source